NDC product
Tramadol Hydrochloride
NDC 0093-3301 · Teva Pharmaceuticals USA, Inc.
Key facts
| Product NDC | 0093-3301 |
|---|---|
| Proprietary name | Tramadol Hydrochloride |
| Nonproprietary name | Tramadol Hydrochloride |
| Substances | TRAMADOL HYDROCHLORIDE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA075977 |
| DEA schedule | CIV |
| Pharmacologic classes | Full Opioid Agonists [MoA], Opioid Agonist [EPC] |
| Marketing start | Sep 12, 2024 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: